Taking precautions with angiotensin converting enzyme inhibitors

BMJ

Volumn 318, Issue 7178, 1999, Pages 257-

  Louden, Jonathan D ^a   Main, John ^a   Murdoch, David R ^b   Chowdhury, Tahseen A ^c   Ferris, Mark ^d   Kumar, A ^e   Asim, M ^e   Davison, A M ^e  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b HAIRMYRES HOSPITAL   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d Lakenham Surgery   (United Kingdom)

^e University Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CHEMICALLY INDUCED DISORDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ARTERY STENOSIS; NOTE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; HUMANS; RENAL ARTERY OBSTRUCTION;

EID: 85007767978     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7178.257     Document Type: Letter

References (18)

1. Kumar A, Asim M, Davison AM. Taking precautions with ACE inhibitors. BMJ 1998; 316: 1921[Free Full Text]. (27 June.)
2. Scoble JE, Cook JR. Individual kidney function in atherosclerotic nephropathy. Nephrol Dial Transplant 1998; 13: 842–844
3. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal micro circulation. Physiol Rev 1996; 76: 425–536
4. Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int 1988; 34: 729–743
5. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997; 15: 1365–1377
6. Kumar A, Asim M, Davison AM. Taking precautions with ACE inhibitors. BMJ 1988; 316: 1921. (27 June.)
7. Bude RO, Rubin JM. Detection of renal artery stenosis with Doppler sonography: it is more complicated than originally thought. Radiology 1995; 196: 612–613
8. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly studyELITE). Lancet 1997; 349: 747–752
9. ISIS-4 Collaborative Group. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685
10. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13–16
11. Kumar A, Asim M, Davison AM. Taking precautions with ACE inhibitors. BMJ 1993; 316: 1921. (27 June.)
12. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456–1462
13. Kumar A, Asim M, Davison AM. Taking precautions with ACE inhibitors. BMJ 1998; 316: 1921. (27 June.)
14. Scoble JE, Cook GJR. Individual kidney function in atherosclerotic nephropathy. Nephrol Dial Transplant 1998; 13: 842–844.
15. Miyamori I, Yasuhara S, Matsubara T, Takasaki H, Takeda R. Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. Am J Hypertens 1988; 1: 359–363
16. Taylor A, Nally J, Aurell M, Blaufox D, Dondi M, Dubovsky E, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med 1996; 37: 1876–1882
17. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet 1997; 349: 747–752.
18. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 1998; 352: 13–16.